Effect of Pemetrexed combined with cis-platinum chemotherapy on matrix metalloproteinase VEGF, NK cells and immune function in patients with non-squamous non-small cell lung cancer

Objective: To explore effect of Pemetrexed combined with cis-platinum chemotherapy on matrix metalloproteinase (MMPs), vascular esandothelial growth factor (VEGF), NK cells and immune function in patients with non-squamous non-small cell lung cancer. Method: A total of 86 cases of non-squamous no...

Full description

Bibliographic Details
Main Authors: Feng Wen, Yan Xiang, Shao-Long Wang
Format: Article
Language:English
Published: Editorial Board of Journal of Hainan Medical University 2017-07-01
Series:Journal of Hainan Medical University
Subjects:
Online Access:http://www.hnykdxxb.com/PDF/201713/28.pdf
id doaj-093e03e8630e463daa883c84557137a2
record_format Article
spelling doaj-093e03e8630e463daa883c84557137a22020-11-25T01:41:49ZengEditorial Board of Journal of Hainan Medical UniversityJournal of Hainan Medical University1007-12371007-12372017-07-012313110113Effect of Pemetrexed combined with cis-platinum chemotherapy on matrix metalloproteinase VEGF, NK cells and immune function in patients with non-squamous non-small cell lung cancerFeng Wen0Yan Xiang1Shao-Long Wang2Department of Oncology, The First Affiliated Hospital of Chengdu Medical College, 610500 Chengdu, ChinaGynecology department, Chengdu Xindu Hospital of traditional Chinese Medicine,610500 Chengdu, ChinaDepartment of Oncology, The First Affiliated Hospital of Chengdu Medical College, 610500 Chengdu, ChinaObjective: To explore effect of Pemetrexed combined with cis-platinum chemotherapy on matrix metalloproteinase (MMPs), vascular esandothelial growth factor (VEGF), NK cells and immune function in patients with non-squamous non-small cell lung cancer. Method: A total of 86 cases of non-squamous non-small cell lung cancer patients were divided into control group (n=44) and observation group (n=42), control group was given docetaxel combined cisplatinum chemotherapy, pemetrexed combined cis-platinum chemotherapy, was applied for observation group. Compared MMP-2, MMP-9, VEGF, NK cells and immune function level before and after treatment in both groups. Results: MMP-2, MMP-9, VEGF, NK cells, CD3+, CD4+, CD8+, CD4+/CD8+ level in both groups before treatment was no significant difference. After treatment, MMP-2, MMP-9, VEGF, CD8+level in both groups was significant lower than before treatment intra-group, and observation was lower than control group, there was significant difference. After treatment, NK cells, CD3+, CD4+, CD8+, CD4+/CD8+ level in both groups was increased dramatically than before treatment of intra-group, moreover, NK cells, CD3+, CD4+, CD8+, CD4+/CD8+level in observation group after treatment was obvious higher than in control group after treatment, there was significant difference. Conclusion: Pemetrexed combined with cis-platinum chemotherapy for non-squamous non-small cell lung cancer could effectively decrease serum MMPs, VEGF level and increase NK cell level, regulate immune function, with definite clinical significance.http://www.hnykdxxb.com/PDF/201713/28.pdfNon-squamous non-small cell lung cancerpemetrexedCis-platinumMetalloproteinaseVascular endothelial growth factorImmune function
collection DOAJ
language English
format Article
sources DOAJ
author Feng Wen
Yan Xiang
Shao-Long Wang
spellingShingle Feng Wen
Yan Xiang
Shao-Long Wang
Effect of Pemetrexed combined with cis-platinum chemotherapy on matrix metalloproteinase VEGF, NK cells and immune function in patients with non-squamous non-small cell lung cancer
Journal of Hainan Medical University
Non-squamous non-small cell lung cancer
pemetrexed
Cis-platinum
Metalloproteinase
Vascular endothelial growth factor
Immune function
author_facet Feng Wen
Yan Xiang
Shao-Long Wang
author_sort Feng Wen
title Effect of Pemetrexed combined with cis-platinum chemotherapy on matrix metalloproteinase VEGF, NK cells and immune function in patients with non-squamous non-small cell lung cancer
title_short Effect of Pemetrexed combined with cis-platinum chemotherapy on matrix metalloproteinase VEGF, NK cells and immune function in patients with non-squamous non-small cell lung cancer
title_full Effect of Pemetrexed combined with cis-platinum chemotherapy on matrix metalloproteinase VEGF, NK cells and immune function in patients with non-squamous non-small cell lung cancer
title_fullStr Effect of Pemetrexed combined with cis-platinum chemotherapy on matrix metalloproteinase VEGF, NK cells and immune function in patients with non-squamous non-small cell lung cancer
title_full_unstemmed Effect of Pemetrexed combined with cis-platinum chemotherapy on matrix metalloproteinase VEGF, NK cells and immune function in patients with non-squamous non-small cell lung cancer
title_sort effect of pemetrexed combined with cis-platinum chemotherapy on matrix metalloproteinase vegf, nk cells and immune function in patients with non-squamous non-small cell lung cancer
publisher Editorial Board of Journal of Hainan Medical University
series Journal of Hainan Medical University
issn 1007-1237
1007-1237
publishDate 2017-07-01
description Objective: To explore effect of Pemetrexed combined with cis-platinum chemotherapy on matrix metalloproteinase (MMPs), vascular esandothelial growth factor (VEGF), NK cells and immune function in patients with non-squamous non-small cell lung cancer. Method: A total of 86 cases of non-squamous non-small cell lung cancer patients were divided into control group (n=44) and observation group (n=42), control group was given docetaxel combined cisplatinum chemotherapy, pemetrexed combined cis-platinum chemotherapy, was applied for observation group. Compared MMP-2, MMP-9, VEGF, NK cells and immune function level before and after treatment in both groups. Results: MMP-2, MMP-9, VEGF, NK cells, CD3+, CD4+, CD8+, CD4+/CD8+ level in both groups before treatment was no significant difference. After treatment, MMP-2, MMP-9, VEGF, CD8+level in both groups was significant lower than before treatment intra-group, and observation was lower than control group, there was significant difference. After treatment, NK cells, CD3+, CD4+, CD8+, CD4+/CD8+ level in both groups was increased dramatically than before treatment of intra-group, moreover, NK cells, CD3+, CD4+, CD8+, CD4+/CD8+level in observation group after treatment was obvious higher than in control group after treatment, there was significant difference. Conclusion: Pemetrexed combined with cis-platinum chemotherapy for non-squamous non-small cell lung cancer could effectively decrease serum MMPs, VEGF level and increase NK cell level, regulate immune function, with definite clinical significance.
topic Non-squamous non-small cell lung cancer
pemetrexed
Cis-platinum
Metalloproteinase
Vascular endothelial growth factor
Immune function
url http://www.hnykdxxb.com/PDF/201713/28.pdf
work_keys_str_mv AT fengwen effectofpemetrexedcombinedwithcisplatinumchemotherapyonmatrixmetalloproteinasevegfnkcellsandimmunefunctioninpatientswithnonsquamousnonsmallcelllungcancer
AT yanxiang effectofpemetrexedcombinedwithcisplatinumchemotherapyonmatrixmetalloproteinasevegfnkcellsandimmunefunctioninpatientswithnonsquamousnonsmallcelllungcancer
AT shaolongwang effectofpemetrexedcombinedwithcisplatinumchemotherapyonmatrixmetalloproteinasevegfnkcellsandimmunefunctioninpatientswithnonsquamousnonsmallcelllungcancer
_version_ 1725039462042304512